ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
승모판 질환 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.2%로 46억 5,000만 달러로 성장할 것입니다. 이 예측 기간의 성장 배경에는 승모판 질환의 보급률 증가, 최소침습적 기술 채택 증가, 심장판막 수술의 기술 혁신 급증, 벤처 캐피탈 투자 증가, 제조업체의 관심 증가 등이 있습니다. 예측 기간의 주요 동향으로는 기술 발전, 트랜스 카테터 기술의 발전, 외과 수술의 기술 발전의 증가를 들 수 있습니다.
향후 5년간 9.2%의 성장률 전망은 지난번 전망치보다 0.3% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 이스라엘과 네덜란드에서 조달한 경카테터 승모판막 성형술 시스템 및 3D 심장초음파 장비의 비용을 상승시켜 치료 지연을 악화시키고 순환기과 예산을 상승시킴으로써 미국 병원에 부담을 가중시킬 가능성이 높습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
혈관성 심장질환의 유병률 증가는 향후 몇 년 동안 승모판 질환 시장의 성장을 촉진할 것으로 예상됩니다. 혈관성 심장질환은 심장에 혈액을 공급하는 혈관이나 심장 자체에 영향을 미치는 질환군을 말합니다. 생활습관 선택, 인구통계학적 변화, 병력, 환경적 영향, 유전적 요인이 복합적으로 작용하여 혈관성 심장질환의 발생률 증가에 기여하고 있습니다. 허혈성 심장질환, 고혈압 등의 병태는 심장의 구조와 기능에 영향을 미쳐 승모판막과 관련된 합병증을 유발하여 간접적으로 승모판 질환으로 이어질 수 있습니다. 예를 들어, 2024년 6월 호주 통계청은 호주 보건 복지 연구소가 실시한 국민 건강 조사 데이터에 따르면 인구 10만 명당 심혈관질환으로 인한 사망률이 2021년 143.7명에서 2022년 148.2명으로 증가했다고 보고했습니다. 그 결과, 혈관성 심장질환의 유병률 증가가 승모판 질환 시장을 주도하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 승모판 질환 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 승모판 질환 시장 : 성장률 분석
세계의 승모판 질환 시장 실적 : 규모와 성장, 2019-2024
세계의 승모판 질환 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 승모판 질환 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 승모판 질환 시장 : 치료 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
승모판 수복술
승모판 치환술
심장재동기화치료
승모판 치료제
세계의 승모판 질환 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
승모판 협착 증
승모판 일탈증
승모판 역류증
세계의 승모판 질환 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
외래 수술 센터
기타 최종사용자
세계의 승모판 질환 시장 : 하위 세분화 승모판 수복술(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
외과적 수복
최소침습 수복
경피적 승모판 수복술
세계의 승모판 질환 시장 : 하위 세분화 승모판 치환술(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
기계변 치환술
생체변 치환술
경카테터 승모판 치환술(TMVR)
세계의 승모판 질환 시장 : 하위 세분화 심장재동기화치료(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
페이스메이커 요법
이식형 제세동기(ICD)
양실페이싱
세계의 승모판 질환 시장 : 하위 세분화 승모판 치료제(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
약물요법
항응고 요법
승모판 수복 기기
제7장 지역별·국가별 분석
세계의 승모판 질환 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 승모판 질환 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
승모판 질환 시장 : 경쟁 구도
승모판 질환 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Boston Scientific Corporation
Edwards Lifesciences
ShockWave Medical Inc.
Artivion Inc.
TTK Health Care Limited
Braile Biomedica
JenaValve Technology Inc.
4C Medical technologies
Labcor Laboratorios Ltda
CryoLife Inc.
Valcare Medical
Affluent Medical
Colibri Heart Valve LLC
Coramaze Technologies
Corcym UK Limited
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
승모판 질환 시장 2029 : 새로운 기회를 제공하는 국가
승모판 질환 시장 2029 : 새로운 기회를 제공하는 부문
승모판 질환 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Mitral valve disease affects the mitral valve, which regulates blood flow between the heart's left atrium and left ventricle. This disorder can cause narrowing or leakage of the valve, disrupting normal blood circulation and leading to symptoms such as breathlessness, fatigue, and irregular heart rhythms. The primary goal in managing mitral valve disease is to maintain proper blood flow through the heart and prevent complications.
Key treatments for mitral valve disease include mitral valve repair, mitral valve replacement, cardiac resynchronization therapy, and mitral valve therapeutics. Mitral valve repair involves surgical or minimally invasive procedures to correct defects or leaks in the mitral valve, aiming to restore its normal function and prevent further health issues. This treatment is used to address conditions such as mitral valve stenosis, mitral valve prolapse, and mitral valve regurgitation, and is administered in settings such as hospitals and ambulatory surgical centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The mitral valve disease market research report is one of a series of new reports from The Business Research Company that provides mitral valve disease market statistics, including the mitral valve disease industry global market size, regional shares, competitors with mitral valve disease market share, detailed mitral valve disease market segments, market trends, and opportunities, and any further data you may need to thrive in the mitral valve disease industry. These mitral valve disease market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The mitral valve disease market size has grown strongly in recent years. It will grow from $3 billion in 2024 to $3.28 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to patient education initiatives, adequate reimbursement policies and insurance coverage, growing healthcare expenditure, rising awareness and screening efforts, and expanding market presence.
The mitral valve disease market size is expected to see strong growth in the next few years. It will grow to $4.65 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing prevalence of mitral valve disease, increasing adoption for minimally invasive techniques, soaring innovations in heart valve surgery, rise venture capital investments, and rising interest of manufacturers. Major trends in the forecast period include technological advancements, advancements in transcatheter technologies, and increasing technological advancements in surgical procedures.
The forecast of 9.2% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. hospitals by driving up the cost of transcatheter mitral valve repair systems and 3D echocardiography equipment sourced from Israel and the Netherlands, exacerbating treatment delays and elevating cardiology department budgets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising prevalence of vascular heart diseases is expected to drive the growth of the mitral valve disease market in the coming years. Vascular heart diseases refer to a group of conditions that impact the blood vessels supplying the heart or the heart itself. A combination of lifestyle choices, demographic changes, medical conditions, environmental influences, and genetic factors contributes to the increasing incidence of vascular heart diseases. Conditions such as ischemic heart disease and hypertension can indirectly lead to mitral valve disease by affecting the heart's structure and function, resulting in complications involving the mitral valve. For example, in June 2024, the Australian Bureau of Statistics reported that the death rate from cardiovascular disease per 100,000 population increased from 143.7 in 2021 to 148.2 in 2022 for males, according to data from the National Health Survey conducted by the Australian Institute of Health and Welfare. As a result, the growing prevalence of vascular heart diseases is driving the mitral valve disease market.
Key companies in the mitral valve disease market are developing stented tissue valves to meet the rising demand for minimally invasive treatment options. These valves are designed to offer durable and reliable performance, providing an alternative to traditional surgical methods. For example, in April 2024, Medtronic, an Ireland-based healthcare company, introduced the Avalus Ultra valve, an advanced surgical aortic tissue valve aimed at improving ease of use during implantation and long-term patient management. Building on a decade of clinical experience with the original Avalus valve, the Avalus Ultra features a low-profile valve for easier implantation, a PEEK base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA), which may enhance blood flow. Additionally, it incorporates a radiopaque coil for better visibility during future valve-in-valve procedures.
In July 2024, Edwards Lifesciences, a US-based medical technology company, acquired Innovative Bio Medical Ltd. for an undisclosed amount. This acquisition is aimed at strengthening Edwards Lifesciences' portfolio of transcatheter mitral valve replacement (TMVR) technologies, helping the company better address unmet needs in structural heart disease and supporting long-term growth. Innovative Bio Medical Ltd., a UK-based medical device company, specializes in developing advanced TMVR technologies.
Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH
Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the mitral valve disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The mitral valve disease market includes revenues earned by entities by providing services such as diagnostic imaging, surgical, and interventional procedures, alongside consultation, rehabilitation, and telemedicine services, catering to patient care and research needs. The market value includes the value of related goods sold by the service provider or included within the service offering. The mitral valve disease market also includes sales of valve repair devices, valve replacement devices, imaging and diagnostic tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mitral Valve Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on mitral valve disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for mitral valve disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mitral valve disease market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Mitral Valve Disease Market Characteristics
3. Mitral Valve Disease Market Trends And Strategies
4. Mitral Valve Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Mitral Valve Disease Growth Analysis And Strategic Analysis Framework
5.1. Global Mitral Valve Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Mitral Valve Disease Market Growth Rate Analysis
5.4. Global Mitral Valve Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Mitral Valve Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Mitral Valve Disease Total Addressable Market (TAM)
6. Mitral Valve Disease Market Segmentation
6.1. Global Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mitral Valve Repair
Mitral Valve Replacement
Cardiac Resynchronization Therapy
Mitral Valve Therapeutics
6.2. Global Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mitral Valve Stenosis
Mitral Valve Prolapse
Mitral Valve Regurgitation
6.3. Global Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centres
Other End-Users
6.4. Global Mitral Valve Disease Market, Sub-Segmentation Of Mitral Valve Repair, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgical Repair
Minimally Invasive Repair
Percutaneous Mitral Valve Repair
6.5. Global Mitral Valve Disease Market, Sub-Segmentation Of Mitral Valve Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mechanical Valve Replacement
Biological Valve Replacement
Transcatheter Mitral Valve Replacement (TMVR)
6.6. Global Mitral Valve Disease Market, Sub-Segmentation Of Cardiac Resynchronization Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pacemaker Therapy
Implantable Cardioverter-Defibrillators (ICD)
Biventricular Pacing
6.7. Global Mitral Valve Disease Market, Sub-Segmentation Of Mitral Valve Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmacological Treatments
Anticoagulation Therapy
Mitral Valve Repair Devices
7. Mitral Valve Disease Market Regional And Country Analysis
7.1. Global Mitral Valve Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Mitral Valve Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
